Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

THC Farmaceuticals Inc

Healthcare US CBDG

0.018USD
0.00(0%)

Last update at 2026-06-03T18:26:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.00330.10
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap0.36M
  • Volume12064
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.06943M
  • Revenue TTM0.02M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.00442M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -0.02995M 0.43M -0.01681M -0.12065M -0.99514M
Minority interest - - - - -
Net income -0.01498M 0.43M -0.00842M -0.06044M -0.49857M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit -0.00495M 0.00619M 0.00128M 0.00758M 0.00756M
Reconciled depreciation - - - - -
Ebit -0.02995M 0.43M -0.01681M -0.12065M -0.99514M
Ebitda -0.02500M 0.43M -0.01585M -0.11970M -0.99419M
Depreciation and amortization 0.00495M 0.00381M 0.00095M 0.00095M 0.00095M
Non operating income net other - - - - -
Operating income -0.02995M -0.00849M -0.01781M -0.03270M -0.15809M
Other operating expenses 0.03M 0.02M 0.02M 0.04M 0.17M
Interest expense - - - - -
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.01498M 0.43M -0.00839M -0.06021M -0.49658M
Total revenue - 0.01000M 0.00223M 0.00758M 0.01M
Total operating expenses -0.02500M 0.01M 0.02M 0.04M 0.17M
Cost of revenue 0.00495M 0.00381M 0.00095M - 0.00263M
Total other income expense net - 0.43M 0.00100M -0.08795M -0.83705M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 2.75M 2.78M 2.80M 2.33M 2.53M
Intangible assets 0.63M 1.64M 1.02M 1.02M 1.23M
Earning assets - - - - -
Other current assets - 0.03M 0.03M 0.03M 0.03M
Total liab 0.14M 0.14M 0.59M 0.55M 1.09M
Total stockholder equity 3.20M 3.22M 2.79M 2.35M 1.96M
Deferred long term liab - - - - -
Other current liab 0.00058M 0.00058M 0.18M 0.18M 0.16M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Capital stock - - - - -
Retained earnings -1.44820M -1.43322M -1.86013M -1.85171M -1.79126M
Other liab - - - - -
Good will 1.01M - - 1.01M 1.01M
Other assets - - - 0.00000M 0.00000M
Cash 0.00171M 0.00171M 0.02M 0.00259M 0.00255M
Cash and equivalents - - - - -
Total current liabilities 0.14M 0.14M 0.59M 0.55M 1.09M
Current deferred revenue - - - - -
Net debt 0.14M 0.14M 0.35M 0.34M 0.91M
Short term debt 0.14M 0.14M 0.37M 0.34M 0.92M
Short long term debt - - - - -
Short long term debt total 0.14M 0.14M 0.37M 0.34M 0.92M
Other stockholder equity 3.98M 3.98M 3.98M 3.54M 3.09M
Property plant equipment - - - - -
Total current assets 0.02M 0.66M 0.68M 0.66M 0.65M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.01M 0.64M 0.63M 0.63M 0.62M
Long term debt - - - - -
Inventory - - - - -
Accounts payable - - 0.03M 0.03M 0.01M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.65M 0.65M 0.65M 0.65M 0.65M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - -1.00718M -1.00718M
Deferred long term asset charges - - - - -
Non current assets total 2.73M 2.11M 2.12M 1.67M 1.88M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -0.63554M 0.02M - - -
Net borrowings - - - - -
Total cash from financing activities - -0.35417M 0.03M 0.00224M 0.11M
Change to operating activities - - - - -
Net income -0.01498M 0.43M -0.00842M -0.06044M -0.49857M
Change in cash - -0.01713M 0.02M 0.00004M -0.02916M
Begin period cash flow 0.00171M 0.02M 0.00259M 0.00255M 0.03M
End period cash flow 0.00171M 0.00171M 0.02M 0.00259M 0.00255M
Total cash from operating activities 0.64M 0.32M -0.01176M -0.00221M -0.13424M
Issuance of capital stock - - - - -
Depreciation 0.00495M 0.00381M 0.00095M 0.00095M 0.00095M
Other cashflows from investing activities -0.00000M - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.62M - -0.00223M -0.00767M -
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.63554M -0.35417M 0.03M 0.00224M 0.11M
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00001M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.65M -0.11283M 0.00409M 0.03M 0.02M
Stock based compensation - - - - -
Other non cash items -0.00495M - -0.00839M 0.03M 0.33M
Free cash flow 0.64M 0.32M -0.01176M -0.00221M -0.13424M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBDG
THC Farmaceuticals Inc		 - -% 0.02 - - 19.58 7.46 441.55 -117.7712
NVO
Novo Nordisk A/S		 -0.92 2.14% 42.00 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 -0.75 1.73% 42.50 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 3.25 0.76% 428.34 29.67 24.33 10.38 5.83 9.33 20.00
REGN
Regeneron Pharmaceuticals Inc		 16.03 2.66% 618.95 29.07 20.12 7.57 3.82 6.95 19.42

Reports Covered

Stock Research & News

View All

Profile

THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.

THC Farmaceuticals Inc

7170 East McDonald Drive, Scottsdale, AZ, United States, 85253

Key Executives

Name Title Year Born
Mr. Ed Rosenthal Pres NA
Mr. Ed Rosenthal President NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions